FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to therapy, and can be used to obtain a drug to inhibit the transport of phosphates in the gastrointestinal tract (GIT). Applications of the invention involve the use of the compound
.
EFFECT: use of inventions allows to treat hyperphosphatemia by inhibiting the uptake of phosphates in the gastrointestinal tract.
20 cl, 15 tbl, 16 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NHE3 BINDING COMPOUNDS AND METHODS FOR PHOSPHATE TRANSPORT INHIBITION | 2014 |
|
RU2786149C2 |
| COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL DISEASES | 2013 |
|
RU2684097C2 |
| METHODS FOR DETERMINING EFFICACY OF LIGANDS OF SODIUM/PROTON ANTIPORTERS | 2009 |
|
RU2519345C2 |
| SELF-DELIVERED RNAI COMPOUNDS OF REDUCED SIZE | 2011 |
|
RU2615143C2 |
| TARGETED CONJUGATES AND PARTICLES AND COMPOSITIONS THEREOF | 2015 |
|
RU2695220C2 |
| METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
| COMPLEMENT ACTIVITY MODULATORS | 2016 |
|
RU2733720C2 |
| COMPLEMENT ACTIVITY MODULATORS | 2016 |
|
RU2769701C2 |
| POLY-LIGAND MEDICINAL CONJUGATES AND USE THEREOF | 2016 |
|
RU2722449C2 |
| ANTIBODIES AGAINST TENB2 CONSTRUCTED WITH CYSTEINE, AND CONJUGATES, ANTIBODY-DRUG | 2008 |
|
RU2505544C2 |
